BTG CASE STUDIES > BIOPHARMACEUTICALS

Implementation Planning for F200 Biotech Acquisition

The Director of Product and Portfolio Management at a F200 biopharmaceutical company needed to replace a team of Big Three consultants who had begun working on the integration of a recent acquisition. Looking for three skilled project managers to round out internal resources and keep the integration on track, she turned…

READ MORE


Preparing a Biopharma Congress Plan

A global biopharma company was preparing to launch two promising treatments in the same therapeutic area. To maximize impact, the head of marketing wanted to develop a comprehensive healthcare provider (HCP) Congress plan that incorporated both therapies. Yet her lean team lacked the bandwidth to…

READ MORE


Oncology Commercial Assessment

The head of commercial development at a global biopharma giant was assessing the outlook for several oncology indications in key Asian markets. The team had already secured secondary research sources, and it had contracted with external agencies to conduct primary research. However, there was no…

READ MORE


Biopharma Due Diligence

A global biopharma company was evaluating an acquisition whose potential indications ranged from gastrointestinal disorders to ophthalmology. With a key leader out on vacation and the deadline for a non-binding term sheet drawing near, the company’s head of Commercial Business Development turned to Business Talent…

READ MORE


Reinventing Consulting

Leaders at this biopharma giant didn’t set out to reinvent the way the company sourced industry experts and management consultants. But after eight years and more than 150 successful projects in functions as diverse as strategy, market access, product launch, lifecycle management, and digital health—across…

READ MORE


Neuroscience Therapeutic Area Strategy

A VP at a major biopharma company was interested in defining his strategy in the neuroscience space. Looking for a more targeted way to assess the opportunity than big consulting firms could provide, he turned to BTG. We deployed two ex-McKinsey life science strategists to…

READ MORE


Send this to a friend